Honz Pharmaceutical Co., Ltd. (SHE:300086)

Honz Pharmaceutical Revenue

Honz Pharmaceutical had revenue of 50.96M CNY in the quarter ending September 30, 2026, a decrease of -45.75%. This brings the company's total for the last twelve months to 335.59M, down -22.33% year-over-year. In the year 2025, Honz Pharmaceutical had annual revenue of 466.12M, down -0.72%. That makes Honz Pharmaceutical the 27,956th largest company in the world by revenue and 4,803rd in China.

• Revenue (ttm): 335.59M
• Revenue Growth: -22.33%
• P/S Ratio: 6.44
• Revenue / Employee: 621.46K
• Employees: 540
• Market Cap: 2.16B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Pharmaceutical Manufacturing and Sales Division 431.30M 91.6%
• Daily Necessities Production and Sales Division 39.74M 8.4%

By Geography

Chart

• China 464.49M 99.7%
• Foreign 1.63M 0.3%

Fiscal year ended Dec 31, 2025 See the full Honz Pharmaceutical breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	466.12M	-3.40M	-0.72%
Jan 1, 2025	469.53M	-270.04M	-36.51%
Dec 31, 2023	739.57M	203.82M	38.05%
Jan 1, 2023	535.75M	-300.82M	-35.96%
Jan 1, 2022	836.57M	-85.08M	-9.23%

Data Source: S&P Global Market Intelligence Last updated: Oct 25, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 11, 2026

Data Sources Report a data error